Home/Filings/4/0001209191-21-039670
4//SEC Filing

Rona Jeffrey A 4

Accession 0001209191-21-039670

CIK 0001636651other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 7:49 PM ET

Size

5.4 KB

Accession

0001209191-21-039670

Insider Transaction Report

Form 4
Period: 2021-06-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-02+100,000100,000 total
    Exercise: $4.42Exp: 2031-06-01Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on June 2, 2022 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001311404

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:49 PM ET
Size
5.4 KB